Akebia Therapeutics, Inc. (AKBA)
1.62
+0.01
(+0.62%)
USD |
NASDAQ |
Dec 16, 16:00
1.62
0.00 (0.00%)
Pre-Market: 08:20
Akebia Therapeutics Accounts Payable (Quarterly): 10.09M for Sept. 30, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Pfizer Inc. | 5.024B |
| Ironwood Pharmaceuticals, Inc. | 1.613M |
| Pyxis Oncology, Inc. | 9.756M |
| Karyopharm Therapeutics, Inc. | 5.392M |
| Theravance Biopharma, Inc. | 2.213M |